Clinical Trials Logo

Filter by:
NCT ID: NCT00849667 Terminated - Ovarian Cancer Clinical Trials

Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse

Start date: April 16, 2009
Phase: Phase 3
Study type: Interventional

This research is being done to find out if Carboplatin and Taxane works better alone or when given with an experimental drug called MORAb-003(farletuzumab) in subjects with first platinum sensitive relapsed ovarian cancer.

NCT ID: NCT00849602 Active, not recruiting - Dengue Clinical Trials

The Effect of Chloroquine in the Treatment of Patients With Dengue

Start date: February 2008
Phase: Phase 1/Phase 2
Study type: Interventional

The objective of this study was to evaluate the effect of chloroquine in the treatment of patients with dengue.

NCT ID: NCT00849381 Completed - Clinical trials for Infections, Papillomavirus

Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Brazil, Taiwan or Thailand

Start date: April 2009
Phase: Phase 3
Study type: Interventional

This phase 3b study is designed to assess the safety of GlaxoSmithKline Biological's HPV vaccine GSK580299 in female subjects who took part in study 008/580299 and received the control vaccine (Hepatitis A vaccine).

NCT ID: NCT00848770 Recruiting - Stroke, Acute Clinical Trials

Manipulation of Arterial Pressure in Acute Ischemic Stroke

MAPAS
Start date: January 2008
Phase: N/A
Study type: Interventional

This is a controlled clinical trial among non thrombolysed acute ischemic stroke patients to determine the effects of three levels of arterial pressure on death and neurological disability. After the admission in the vascular unit of the Emergency Department the patients are randomized to maintain during the first 24h the Systolic Arterial Pressure in tree levels of pressure: 140 to 160 mmHg; 161 to 180 mmHg and 181 to 200 mmHg. The end point of the study is the Modified Rankin score and mortality in three month after the discharge.

NCT ID: NCT00847613 Completed - Clinical trials for Arthritis, Rheumatoid

A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate

Start date: March 2009
Phase: Phase 3
Study type: Interventional

This study is designed to provide safety and efficacy data to support the development of CP-690,550 in patients with moderate to severe rheumatoid arthritis on background of methotrexate.

NCT ID: NCT00845728 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Exacerbation Study

INVIGORATE
Start date: March 2009
Phase: Phase 3
Study type: Interventional

This study compares indacaterol with tiotropium in terms of bronchodilation over 52 weeks

NCT ID: NCT00845637 Completed - Dyslipidemia Clinical Trials

Effect of Eggplant Extract on Lipid Profile During Fasting and Postprandial Period

Start date: March 2004
Phase: Phase 1
Study type: Interventional

The purpose of this study was to assess the effect of eggplant extract capsules on the lipid profile of healthy individuals after an oral lipid overload test in a randomized, double-blind, placebo-controlled clinical trial.

NCT ID: NCT00844662 Terminated - Clinical trials for Chronic Kidney Failure

Phase III Study to Investigate the Safety and Efficacy of Fermagate and Sevelamer Hydrochloride

Start date: July 2009
Phase: Phase 3
Study type: Interventional

Magnesium iron hydroxycarbonate is a phosphate binder that absorbs phosphate from food, reducing the amount that the body can absorb. The purpose of this study is to assess the efficacy of magnesium iron hydroxycarbonate in subjects requiring haemodialysis, compared with a marketed phosphate binder, sevelamer hydrochloride.

NCT ID: NCT00844259 Completed - Down Syndrome Clinical Trials

Functional Communicative Profile of Children With Down Syndrome

Start date: July 2006
Phase: N/A
Study type: Observational

The aim of this study was to verify the use of communicative functions by children with DS in two interaction conditions: interaction with therapist and interaction with parent.

NCT ID: NCT00844038 Completed - Clinical trials for Stevens-Johnson Syndrome

Stevens-Johnson Syndrome Antimicrobial

Start date: August 2008
Phase: N/A
Study type: Observational

Steven-Johnson's syndrome, or great multiform erythema, appears as a systemic disturbance, with skin involvement and mucous membranes, related to several factors, such as, viral or bacterial infections and mainly the administration of medicines, in general painkillers and antibiotics. The objective of this work is report the emergence of ulcerative vesicle -bubble chronic disease in areas of lips, gum, tongue and genital mucous membrane in a 26 year-old patient, leucoderma and masculine gender, in treatment of breathing infection with sulfametoxazol-trimetropima, having been diagnosed as syndrome of Steven-Johnson.